Trump opioid plan writes in favoritism to single company's addiction medication
Opiods (npr.org)

WASHINGTON - The White House's national strategy to combat the opioid crisis, unveiled last week, would expand a particular kind of addiction treatment in federal criminal justice settings: a single drug, manufactured by a single company, with mixed views on the evidence regarding its use.